FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Moderna (NASDAQ: MRNA) reported Q1 EPS of $2.84, $0.45 better than the analyst estimate of $2.39. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $2.44 billion.
2021 Updated Financial Framework
Advance Purchase Agreements (APAs): The Company has already signed APAs for scheduled... More
